The overall 5-year relative survival rate for AML is about 30%, but this number is an estimate based on a large group of people and does not predict individual outcomes. Younger people with AML tend ...

As consolidation therapy for acute myeloid leukemia (AML), allogeneic hematopoietic stem-cell transplantation provides a benefit in part by means of an immune-mediated graft-versus-leukemia effect. We ...

Acute myeloid leukemia (AML) is a cancer that occurs in the blood and bone marrow. In its early stages, the symptoms of AML may resemble the flu, and you may have a fever and fatigue. Treatment for ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. Led by Mikkael ...

As someone with acute myeloid leukemia (AML), the best choice you can make is to receive care at an academic medical center, like Fred Hutch Cancer Center, from physicians who specialize in AML.

Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies Current data highlight the potential role for immunotherapy in AML. Gaps in knowledge include limited studies on ...

Acute monocytic leukemia is a subtype of acute myeloid leukemia (AML) and is denoted as AML-5 or M5. This subtype of AML has distinct clinical and biological characteristics and is associated with ...